Latest News by Industry
HERCULES, Calif.--(BUSINESS WIRE)--Nov 21, 2024--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will host one-on-one meetings with analysts and investors during Citi's 2024 Global Healthcare Conference in Miami, FL, December 3-5, 2024.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241121721098/en/
CONTACT: Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.comMedia Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH OTHER MANUFACTURING HEALTH HOSPITALS MANUFACTURING CLINICAL TRIALS
SOURCE: Bio-Rad Laboratories, Inc.
Copyright Business Wire 2024.
PUB: 11/21/2024 09:00 AM/DISC: 11/21/2024 09:03 AM
http://www.businesswire.com/news/home/20241121721098/en